Axon price target lowered to $800 from $940 at Goldman Sachs

Goldman Sachs analyst Michael Ng lowered the firm’s price target on Axon (AXON) to $800 from $940 and keeps a Buy rating on the shares. Axon missed Q3 gross profit and bookings expectations due to timing-related weakness in Software & Services, though Connected Devices performed solidly across TASER, sensors, and platforms, the analyst tells investors in a research note. Management guided to a strong Q4 rebound, reiterating high bookings growth and highlighting growing international and retail demand, including major overseas deals. Ongoing adoption of the AI Era Plan and acquisitions of Carbyne and Prepared position AXON to modernize 911 operations, though near-term financial impact remains minimal, Goldman says.